Shirasawa M, Yoshida T, Takayanagi D, Shiraishi K, et al. Activity and Immune Correlates of Programmed Death-1 Blockade Therapy in Patients With Advanced Large Cell Neuroendocrine Carcinoma. Clin Lung Cancer 2021;22:282-291.
PMID: 33722498